Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2001
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1142999A1 Novel protein and dna thereof
10/10/2001EP1142910A1 Inhibitors for the formation of soluble human CD23
10/10/2001EP1142904A1 Sponge protein hydrolysates and methods of producing the same
10/10/2001EP1142900A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same
10/10/2001EP1142893A1 Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142886A1 Percyquinnin, a process for its production and its use as a pharmaceutical
10/10/2001EP1142885A1 Novel 2-(n-cyanoimino)thiazolidin-4-one derivatives
10/10/2001EP1142879A1 Imidazole compounds and medicinal use thereof
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1142581A2 Tissue sealant and growth factor containing compositions that promote accelerated wound healing
10/10/2001EP1142579A2 Bone resorption inhibitors
10/10/2001EP1141723A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists
10/10/2001EP1141376A1 Peptidoglycan recognition proteins
10/10/2001EP1141357A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
10/10/2001EP1141332A1 Human cyclic nucleotide pdes
10/10/2001EP1141326A2 Human akt-3
10/10/2001EP1141325A1 Ikk3 kinase
10/10/2001EP1141319A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation
10/10/2001EP1141300A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity
10/10/2001EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001EP1141277A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof
10/10/2001EP1141253A1 Crystalline form of activated trap and use thereof for structure-based drug design
10/10/2001EP1141251A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
10/10/2001EP1141241A2 Astrocytes, their preparation and uses thereof
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease
10/10/2001EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001EP1141024A2 Polypeptide variants with altered effector function
10/10/2001EP1141022A1 Serine protease inhibitor
10/10/2001EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/10/2001EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
10/10/2001EP1141017A2 Characterization of the soc/crac calcium channel protein family
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1141006A1 Topoisomerase ii inhibitor
10/10/2001EP1141003A1 Methods
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140987A1 Peptides for inhibiting hpv e6 proteins
10/10/2001EP1140984A1 Selective inhibitors of mmp-12
10/10/2001EP1140983A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors
10/10/2001EP1140981A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
10/10/2001EP1140970A1 47 human secreted proteins
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140946A2 Quinoline derivatives
10/10/2001EP1140944A1 Epothilone derivatives and their use as antitumor agents
10/10/2001EP1140943A2 Substituted pyrroloindoles
10/10/2001EP1140938A2 High affinity inhibitors for target validation and uses thereof
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140934A1 BENZISOXAZOLES AND PHENONES AS $g(a) 2?-ANTAGONISTS
10/10/2001EP1140931A1 5ht1 antagonists for antidepressant therapy
10/10/2001EP1140930A1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
10/10/2001EP1140925A1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140909A1 Novel inhibitors of farnesyl-protein transferase
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140904A1 Farnesyl protein transferase inhibitors
10/10/2001EP1140902A1 Tricyclic farnesyl protein transferase inhibitors
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140900A2 Pyrazole compounds and uses thereof
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140888A1 Optical molecular sensors for cytochrome p450 activity
10/10/2001EP1140882A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140867A1 New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140855A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140851A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140830A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140820A1 New amidino derivatives and their use as thrombin inhibitors
10/10/2001EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140790A1 Novel oxo-aminotetralin compounds useful in pain management
10/10/2001EP1140786A1 Reductive alkylation of secondary amines with hydrosilane
1 ... 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 ... 1564